EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866

Daisuke Taguchi iD, Yohei Shirakami iD, Hiroyasu Sakai iD, Daisuke Minowa, Takao Miwa iD, Toshihide Maeda, Masaya Kubota, Kenji Imai, Takashi Ibuka, Masahito Shimizu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26030978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Daisuke Taguchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. Hauptthemen laut MEDLINE: Canagliflozin, Cholangiocarcinoma, Bile Duct Neoplasms, Acrylamides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholangiocarcinoma-associated mortality has been increasing over the past decade. The sodium-glucose cotransporter 2 inhibitor, canagliflozin, has demonstrated anti-tumor effects against several types of cancers; however, studies examining its potential impact on cholangiocarcinoma are lacking. This study investigated the anti-tumor effects of canagliflozin on cholangiocarcinoma and the effects of nicotinamide adenine dinucleotide (NAD)+ salvage pathway activation and sirtuin 1 on tumor growth. We evaluated cell proliferation and gene expression in several cholangiocarcinoma cell lines and analyzed the effects of canagliflozin on cell proliferation, apoptosis, and migration. Canagliflozin treatment decreased the viability of cholangiocarcinoma cells in a concentration-dependent manner but increased the viability at low concentrations in several cell lines. At high concentrations, canagliflozin arrested the cell cycle checkpoint in the G0/G1 phase. In contrast, at low concentrations, it increased the proportion of cells in the S phase. Canagliflozin also reduced the migratory ability of cholangiocarcinoma cells in a concentration-dependent manner. Canagliflozin treatment upregulated nicotinamide phosphoribosyltransferase (NAMPT), NAD+, and sirtuin 1 in cholangiocarcinoma and activated the NAD+ salvage pathway. The growth-inhibitory effect of canagliflozin was enhanced when combined with an NAMPT inhibitor. Canagliflozin inhibits cholangiocarcinoma cell growth and migration and its anti-tumor effect is enhanced when combined with an NAMPT inhibitor. However, further investigation is required because of its potential tumor growth-promoting effect through the activation of the NAD+ salvage pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CanagliflozinCholangiocarcinomaBile Duct NeoplasmsAcrylamidesPiperidinesPiperazinesHumansCell ProliferationCell Line, TumorCell MovementApoptosisNicotinamide PhosphoribosyltransferaseSirtuin 1Cell SurvivalNADCytokinesGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

canagliflozincholangiocarcinomanicotinamide adenine dinucleotide+nicotinamide phosphoribosyltransferasesirtuin 1

Substanzen

CanagliflozinN-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamideAcrylamidesPiperidinesNicotinamide PhosphoribosyltransferaseSirtuin 1PiperazinesNADnicotinamide phosphoribosyltransferase, humanCytokines

Autor:innen und Institutionen

  • Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

ORCID-Profile: Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, Takao Miwa

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Taguchi, D., Shirakami, Y., Sakai, H., Minowa, D., Miwa, T., Maeda, T., Kubota, M., Imai, K., Ibuka, T., & Shimizu, M. (2025). Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26030978

Vancouver

Taguchi D, Shirakami Y, Sakai H, Minowa D, Miwa T, Maeda T, et al. Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26030978

BibTeX
@article{Taguchi2025,
  author = {Taguchi, Daisuke and Shirakami, Yohei and Sakai, Hiroyasu and Minowa, Daisuke and Miwa, Takao and Maeda, Toshihide and Kubota, Masaya and Imai, Kenji and Ibuka, Takashi and Shimizu, Masahito},
  title = {Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26030978}
}
Kostenlos starten →